Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

Background - The vast majority of COVID-19 patients experience a mild disease. However, a minority suffers from critical disease with substantial morbidity and mortality. - Objectives - To identify individuals at risk of critical COVID-19, the relevance of a seroreactivity against seasonal human cor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dugas, Martin (VerfasserIn) , Grote-Westrick, Tanja (VerfasserIn) , Merle, Uta (VerfasserIn) , Fontenay, Michaela (VerfasserIn) , Kremer, Andreas E. (VerfasserIn) , Hanses, Frank (VerfasserIn) , Vollenberg, Richard (VerfasserIn) , Lorentzen, Eva (VerfasserIn) , Tiwari-Heckler, Shilpa (VerfasserIn) , Duchemin, Jérôme (VerfasserIn) , Ellouze, Syrine (VerfasserIn) , Vetter, Marcel (VerfasserIn) , Fürst, Julia (VerfasserIn) , Schuster, Philipp (VerfasserIn) , Brix, Tobias (VerfasserIn) , Denkinger, Claudia M. (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Schmidt, Hartmut (VerfasserIn) , Tepasse, Phil-Robin (VerfasserIn) , Kühn, Joachim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 24 April 2021
In: Clinical and diagnostic virology
Year: 2021, Jahrgang: 139, Pages: 1-9
ISSN:1873-4901
DOI:10.1016/j.jcv.2021.104847
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jcv.2021.104847
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1386653221001141
Volltext
Verfasserangaben:Martin Dugas, Tanja Grote-Westrick, Uta Merle, Michaela Fontenay, Andreas E. Kremer, Frank Hanses, Richard Vollenberg, Eva Lorentzen, Shilpa Tiwari-Heckler, Jérôme Duchemin, Syrine Ellouze, Marcel Vetter, Julia Fürst, Philipp Schuster, Tobias Brix, Claudia M. Denkinger, Carsten Müller-Tidow, Hartmut Schmidt, Phil-Robin Tepasse, Joachim Kühn

MARC

LEADER 00000caa a2200000 c 4500
001 1762549646
003 DE-627
005 20220820013553.0
007 cr uuu---uuuuu
008 210709s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jcv.2021.104847  |2 doi 
035 |a (DE-627)1762549646 
035 |a (DE-599)KXP1762549646 
035 |a (OCoLC)1341418080 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dugas, Martin  |e VerfasserIn  |0 (DE-588)1131361393  |0 (DE-627)886028701  |0 (DE-576)487948939  |4 aut 
245 1 0 |a Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19  |c Martin Dugas, Tanja Grote-Westrick, Uta Merle, Michaela Fontenay, Andreas E. Kremer, Frank Hanses, Richard Vollenberg, Eva Lorentzen, Shilpa Tiwari-Heckler, Jérôme Duchemin, Syrine Ellouze, Marcel Vetter, Julia Fürst, Philipp Schuster, Tobias Brix, Claudia M. Denkinger, Carsten Müller-Tidow, Hartmut Schmidt, Phil-Robin Tepasse, Joachim Kühn 
246 3 3 |a Lack of antibodies against seasonal coronavirus OC forty-three nucleocapsid protein identifies patients at risk of critical COVID-nineteen 
264 1 |c 24 April 2021 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.07.2021 
520 |a Background - The vast majority of COVID-19 patients experience a mild disease. However, a minority suffers from critical disease with substantial morbidity and mortality. - Objectives - To identify individuals at risk of critical COVID-19, the relevance of a seroreactivity against seasonal human coronaviruses was analyzed. - Methods - We conducted a multi-center non-interventional study comprising 296 patients with confirmed SARS-CoV-2 infections from four tertiary care referral centers in Germany and France. The ICU group comprised more males, whereas the outpatient group contained a higher percentage of females. For each patient, the serum or plasma sample obtained closest after symptom onset was examined by immunoblot regarding IgG antibodies against the nucleocapsid protein (NP) of HCoV 229E, NL63, OC43 and HKU1. - Results - Median age was 60 years (range 18-96). Patients with critical disease (n=106) had significantly lower levels of anti-HCoV OC43 nucleocapsid protein (NP)-specific antibodies compared to other COVID-19 inpatients (p=0.007). In multivariate analysis (adjusted for age, sex and BMI), OC43 negative inpatients had an increased risk of critical disease (adjusted odds ratio (AOR) 2.68 [95% CI 1.09 - 7.05]), higher than the risk by increased age or BMI, and lower than the risk by male sex. A risk stratification based on sex and OC43 serostatus was derived from this analysis. - Conclusions - Our results suggest that prior infections with seasonal human coronaviruses can protect against a severe course of COVID-19. Therefore, anti-OC43 antibodies should be measured for COVID-19 inpatients and considered as part of the risk assessment for each patient. Hence, we expect individuals tested negative for anti-OC43 antibodies to particularly benefit from vaccination against SARS-CoV-2, especially with other risk factors prevailing. 
650 4 |a COVID-19 
650 4 |a Critical disease 
650 4 |a OC43 
650 4 |a SARS-CoV-2 
650 4 |a Seasonal coronavirus 
700 1 |a Grote-Westrick, Tanja  |e VerfasserIn  |4 aut 
700 1 |a Merle, Uta  |d 1974-  |e VerfasserIn  |0 (DE-588)123211069  |0 (DE-627)706210174  |0 (DE-576)293606854  |4 aut 
700 1 |a Fontenay, Michaela  |e VerfasserIn  |4 aut 
700 1 |a Kremer, Andreas E.  |e VerfasserIn  |4 aut 
700 1 |a Hanses, Frank  |e VerfasserIn  |4 aut 
700 1 |a Vollenberg, Richard  |e VerfasserIn  |4 aut 
700 1 |a Lorentzen, Eva  |e VerfasserIn  |4 aut 
700 1 |a Tiwari-Heckler, Shilpa  |d 1988-  |e VerfasserIn  |0 (DE-588)1081681799  |0 (DE-627)846465655  |0 (DE-576)454652968  |4 aut 
700 1 |a Duchemin, Jérôme  |e VerfasserIn  |4 aut 
700 1 |a Ellouze, Syrine  |e VerfasserIn  |4 aut 
700 1 |a Vetter, Marcel  |e VerfasserIn  |4 aut 
700 1 |a Fürst, Julia  |e VerfasserIn  |4 aut 
700 1 |a Schuster, Philipp  |e VerfasserIn  |4 aut 
700 1 |a Brix, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Denkinger, Claudia M.  |d 1978-  |e VerfasserIn  |0 (DE-588)131597701  |0 (DE-627)511279469  |0 (DE-576)298613727  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Schmidt, Hartmut  |e VerfasserIn  |4 aut 
700 1 |a Tepasse, Phil-Robin  |e VerfasserIn  |4 aut 
700 1 |a Kühn, Joachim  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Clinical and diagnostic virology  |d Amsterdam [u.a.] : Elsevier Science, 1993  |g 139(2021) vom: Juni, Artikel-ID 104847, Seite 1-9  |h Online-Ressource  |w (DE-627)306654539  |w (DE-600)1499932-8  |w (DE-576)121465446  |x 1873-4901  |7 nnas  |a Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19 
773 1 8 |g volume:139  |g year:2021  |g month:06  |g elocationid:104847  |g pages:1-9  |g extent:9  |a Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19 
856 4 0 |u https://doi.org/10.1016/j.jcv.2021.104847  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1386653221001141  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210709 
993 |a Article 
994 |a 2021 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 17 
998 |g 131597701  |a Denkinger, Claudia M.  |m 131597701:Denkinger, Claudia M.  |d 910000  |d 911700  |d 50000  |e 910000PD131597701  |e 911700PD131597701  |e 50000PD131597701  |k 0/910000/  |k 1/910000/911700/  |k 0/50000/  |p 16 
998 |g 1081681799  |a Tiwari-Heckler, Shilpa  |m 1081681799:Tiwari-Heckler, Shilpa  |d 910000  |d 910100  |e 910000PT1081681799  |e 910100PT1081681799  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 123211069  |a Merle, Uta  |m 123211069:Merle, Uta  |d 910000  |d 910100  |d 50000  |e 910000PM123211069  |e 910100PM123211069  |e 50000PM123211069  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
998 |g 1131361393  |a Dugas, Martin  |m 1131361393:Dugas, Martin  |d 910000  |d 999701  |e 910000PD1131361393  |e 999701PD1131361393  |k 0/910000/  |k 1/910000/999701/  |p 1  |x j 
999 |a KXP-PPN1762549646  |e 3947032005 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Martin Dugas, Tanja Grote-Westrick, Uta Merle, Michaela Fontenay, Andreas E. Kremer, Frank Hanses, Richard Vollenberg, Eva Lorentzen, Shilpa Tiwari-Heckler, Jérôme Duchemin, Syrine Ellouze, Marcel Vetter, Julia Fürst, Philipp Schuster, Tobias Brix, Claudia M. Denkinger, Carsten Müller-Tidow, Hartmut Schmidt, Phil-Robin Tepasse, Joachim Kühn"]},"titleAlt":[{"title":"Lack of antibodies against seasonal coronavirus OC forty-three nucleocapsid protein identifies patients at risk of critical COVID-nineteen"}],"id":{"doi":["10.1016/j.jcv.2021.104847"],"eki":["1762549646"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"24 April 2021"}],"person":[{"family":"Dugas","given":"Martin","role":"aut","display":"Dugas, Martin"},{"family":"Grote-Westrick","role":"aut","given":"Tanja","display":"Grote-Westrick, Tanja"},{"family":"Merle","role":"aut","given":"Uta","display":"Merle, Uta"},{"family":"Fontenay","role":"aut","given":"Michaela","display":"Fontenay, Michaela"},{"display":"Kremer, Andreas E.","role":"aut","given":"Andreas E.","family":"Kremer"},{"family":"Hanses","given":"Frank","role":"aut","display":"Hanses, Frank"},{"family":"Vollenberg","role":"aut","given":"Richard","display":"Vollenberg, Richard"},{"display":"Lorentzen, Eva","given":"Eva","role":"aut","family":"Lorentzen"},{"display":"Tiwari-Heckler, Shilpa","given":"Shilpa","role":"aut","family":"Tiwari-Heckler"},{"display":"Duchemin, Jérôme","given":"Jérôme","role":"aut","family":"Duchemin"},{"family":"Ellouze","given":"Syrine","role":"aut","display":"Ellouze, Syrine"},{"family":"Vetter","given":"Marcel","role":"aut","display":"Vetter, Marcel"},{"display":"Fürst, Julia","family":"Fürst","given":"Julia","role":"aut"},{"display":"Schuster, Philipp","given":"Philipp","role":"aut","family":"Schuster"},{"display":"Brix, Tobias","family":"Brix","given":"Tobias","role":"aut"},{"family":"Denkinger","role":"aut","given":"Claudia M.","display":"Denkinger, Claudia M."},{"family":"Müller-Tidow","role":"aut","given":"Carsten","display":"Müller-Tidow, Carsten"},{"display":"Schmidt, Hartmut","family":"Schmidt","given":"Hartmut","role":"aut"},{"family":"Tepasse","given":"Phil-Robin","role":"aut","display":"Tepasse, Phil-Robin"},{"display":"Kühn, Joachim","role":"aut","given":"Joachim","family":"Kühn"}],"relHost":[{"pubHistory":["1.1993/94 - 10.1998,2/3"],"origin":[{"dateIssuedDisp":"1993-1998","dateIssuedKey":"1993","publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science"}],"note":["Gesehen am 14.02.24"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"year":"2021","pages":"1-9","extent":"9","volume":"139","text":"139(2021) vom: Juni, Artikel-ID 104847, Seite 1-9"},"title":[{"title_sort":"Clinical and diagnostic virology","title":"Clinical and diagnostic virology"}],"id":{"eki":["306654539"],"issn":["1873-4901"],"zdb":["1499932-8"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"306654539","disp":"Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19Clinical and diagnostic virology"}],"title":[{"title":"Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19","title_sort":"Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 09.07.2021"],"recId":"1762549646","physDesc":[{"extent":"9 S."}]} 
SRT |a DUGASMARTILACKOFANTI2420